Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Taiwan urged to protect medical technology market with care financing reforms:

This article was originally published in Clinica

Executive Summary

Taiwan has been called upon by the US to "revamp" its National Health Insurance (NHI) framework to reduce barriers to the introduction of new medical technologies. In a "white paper" issued on May 30, the American Chamber of Commerce (AMCHAM) in Taiwan says that the country's financial deficit is threatening the current success of the NHI. "Maintaining this high standard of healthcare for the general populace is becoming increasingly difficult-If no solution is found, the introduction of new medical technology will be sacrificed." Taiwan's ministry of economic affairs (MOEA) has welcomed AMCHAM's recommendations, which include tightening intellectual property protection, upgrading the public healthcare system and accelerating economic integration with China.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT052036

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel